Allogeneic Stem Cell Transplantation Combined With Transfusion of Mesenchymal Stem Cells in Primary Myelofibrosis: A Multicenter Retrospective Study

BackgroundAllogeneic stem cell transplantation (allo-SCT) remains the only effective curative therapy for primary myelofibrosis. Utilization and efficacy of allo-SCT are limited by lethal complications, including engraftment failure, and acute (aGVHD) and chronic graft-versus-host disease (cGVHD). S...

Полное описание

Библиографические подробности

Главные авторы:	Qingyuan Wang, Na Xu, Yu Wang, Xi Zhang, Limin Liu, Huifen Zhou, Hong Wang, Xiang Zhang, Xiaowen Tang, Chengcheng Fu, Miao Miao, Depei Wu
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2022-01-01
Серии:	Frontiers in Oncology
Предметы:	primary myelofibrosis allogeneic stem cell transplantation mesenchymal stem cells graft failure overall survival
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fonc.2021.792142/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!